Skip to Content

Gardasil 9 Dosage

Generic name: Human Papillomavirus Type 6 L1 Capsid Protein Antigen 30ug in 0.5mL, Human Papillomavirus Type 11 L1 Capsid Protein Antigen 40ug in 0.5mL, Human Papillomavirus Type 16 L1 Capsid Protein Antigen 60ug in 0.5mL, Human Papillomavirus Type 18 L1 Capsid Protein Antigen 40ug in 0.5mL, Human Papillomavirus Type 31 L1 Capsid Protein Antigen 20ug in 0.5mL, Human Papillomavirus Type 33 L1 Capsid Protein Antigen 20ug in 0.5mL, Human Papillomavirus Type 45 L1 Capsid Protein Antigen 20ug in 0.5mL, Human Papillomavirus Type 52 L1 Capsid Protein Antigen 20ug in 0.5mL, Human Papillomavirus Type 58 L1 Capsid Protein Antigen 20ug in 0.5mL
Dosage form: suspension for intramuscular injection

See also:

Medically reviewed by Drugs.com. Last updated on Aug 20, 2020.

For intramuscular use only

Dosage

Each dose of GARDASIL 9 is 0.5-mL.

Administer GARDASIL 9 as follows:

Age Regimen Schedule
*
If the second dose is administered earlier than 5 months after the first dose, administer a third dose at least 4 months after the second dose. [See Clinical Studies (14.2 and 14.6).]
9 through 14 years 2-dose 0, 6 to 12 months*
3-dose 0, 2, 6 months
15 through 45 years 3-dose 0, 2, 6 months

Method of Administration

  • Do not dilute or mix GARDASIL 9 with other vaccines.
  • Shake well immediately before use to maintain suspension of the vaccine.
  • Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use the product if particulates are present or if it appears discolored. After thorough agitation, GARDASIL 9 is a white cloudy liquid.
  • Administer intramuscularly in the deltoid or anterolateral area of the thigh.
  • Observe patients for 15 minutes after administration [see Warnings and Precautions (5)].

Single-Dose Vial Use

Withdraw the 0.5-mL dose of vaccine from the single-dose vial using a sterile needle and syringe and use promptly. Discard vial after use.

Prefilled Syringe Use

This package does not contain a needle. Shake well before use. Attach a needle by twisting in a clockwise direction until the needle fits securely on the syringe. Administer the entire dose as per standard protocol. Discard syringe after use.

Administration of GARDASIL 9 in Individuals Who Have Been Previously Vaccinated with GARDASIL®

Safety and immunogenicity were assessed in individuals who completed a three-dose vaccination series with GARDASIL 9 and had previously completed a three-dose vaccination series with GARDASIL [see Adverse Reactions (6.1) and Clinical Studies (14.5)]. Studies using a mixed regimen of HPV vaccines to assess interchangeability were not performed for GARDASIL 9.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.